Legal Representation
Attorney
Maria Luisa Palmese
USPTO Deadlines
Application History
49 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 18, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| May 18, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 27, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 27, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 4, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 3, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Aug 28, 2019 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 3, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 28, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 24, 2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 24, 2019 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 12, 2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 12, 2019 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 12, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 14, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 12, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 12, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Mar 12, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 1, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 30, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 30, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 30, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 1, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 30, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 30, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 30, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 26, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 24, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 24, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 24, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 14, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 17, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 17, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 28, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 5, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 5, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 5, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 5, 2016 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 5, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 17, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 17, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 17, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 25, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 25, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 25, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 19, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 9, 2016 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 8, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 6, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the care and treatment of ophthalmic diseases; saffron sold as a component of pharmaceutical preparations for the care and treatment of ophthalmic diseases; saffron sold as a component of nutritional supplements
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the term "REPRON" in lower case letters with the letters "RE" in bold and a seedling sprouting from the letter "O."
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005